A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
Open Access
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 73, 174-188
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (POIG.01.03.01-30-049/09)
- Innovative Economy Programme (POIG.01.03.01-30-098/08)
- National Science Centre (DEC-2013/08/T/NZ4/00712)
- Polish Ministry of Science and Higher Education (N N302 299536)
This publication has 49 references indexed in Scilit:
- Measuring Motor Coordination in MiceJournal of Visualized Experiments, 2013
- Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic MicePLOS ONE, 2013
- Mouse Models of Polyglutamine Diseases: Review and Data Table. Part IMolecular Neurobiology, 2012
- Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part IIMolecular Neurobiology, 2012
- Genomic Analysis of Reactive AstrogliosisThe Journal of Neuroscience, 2012
- Machado–Joseph disease/spinocerebellar ataxia type 32012
- Neuroprotective effects of granulocyte‐colony stimulating factor in a novel transgenic mouse model of SCA17Journal of Neurochemistry, 2011
- Mouse Ataxin-3 Functional Knock-Out ModelNeuroMolecular Medicine, 2010
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3Journal of Neuroscience, 2008
- Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph diseaseHuman Mutation, 1998